» Authors » Parvin Ganjei-Azar

Parvin Ganjei-Azar

Explore the profile of Parvin Ganjei-Azar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 629
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Grobman A, Vivero R, Campuzano-Zuluaga G, Ganjei-Azar P, Rosow D
Case Rep Oncol Med . 2012 Dec; 2012:257814. PMID: 23213583
The objectives of this paper are to discuss a rare cause of laryngeal multiple myeloma, to review unique pathologic findings associated with plasma cell neoplasms, to discuss epidemiology, differential diagnosis,...
12.
Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, et al.
Brain Behav Immun . 2012 Aug; 30 Suppl:S126-34. PMID: 22884960
Elevations in the pro-inflammatory cytokine interleukin-6 (IL-6) and alterations in the anti-inflammatory hormone cortisol have been reported in a variety of cancers. IL-6 has prognostic significance in ovarian cancer and...
13.
Lutgendorf S, De Geest K, Bender D, Ahmed A, Goodheart M, Dahmoush L, et al.
J Clin Oncol . 2012 Jul; 30(23):2885-90. PMID: 22802321
Purpose: Previous research has demonstrated relationships of social support with disease-related biomarkers in patients with ovarian cancer. However, the clinical relevance of these findings to patient outcomes has not been...
14.
Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge D, Krischer J
Arch Intern Med . 2011 Aug; 171(15):1363-9. PMID: 21824950
Background: Concerns regarding the risk of estrogen replacement have resulted in a significant increase in the use of soy products by menopausal women who, despite the lack of evidence of...
15.
Capo-Chichi C, Cai K, Smedberg J, Ganjei-Azar P, Godwin A, Xu X
Chin J Cancer . 2011 Jun; 30(6):415-25. PMID: 21627864
Through advances in technology, the genetic basis of cancer has been investigated at the genomic level, and many fundamental questions have begun to be addressed. Among several key unresolved questions...
16.
Capo-Chichi C, Cai K, Simpkins F, Ganjei-Azar P, Godwin A, Xu X
BMC Med . 2011 Mar; 9:28. PMID: 21439080
Background: Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of...
17.
Cioffi-Lavina M, Chapman-Fredricks J, Gomez-Fernandez C, Ganjei-Azar P, Manoharan M, Jorda M
Appl Immunohistochem Mol Morphol . 2010 Jun; 18(4):344-7. PMID: 20571342
Context/objective: p16 is a widely used immunohistochemical marker in gynecologic pathology. Strong and diffuse cytoplasmic and nuclear expression of p16 in squamous cell carcinomas (SCC) of the female genital tract...
18.
Ardalan B, Subbarayan P, Ramos Y, Gonzalez M, Fernandez A, Mezentsev D, et al.
Clin Cancer Res . 2010 May; 16(11):3019-27. PMID: 20501625
Purpose: This Phase I study was designed to determine a safe combination dose of 5-fluorouracil (5-FU) and arsenic trioxide (ATO) to treat 5-FU-resistant relapsed/refractory colorectal cancer patients. We studied the...
19.
Krishan A, Sharma D, Sharma S, Hamelik R, Ganjei-Azar P, Nadji M
Cytometry B Clin Cytom . 2010 Jan; 78(3):176-82. PMID: 20043317
Background: Enhanced expression of aldehyde dehydrogenase 1 (ALDH1) and phenotypic markers (CD44(+)/CD24(-)) in stem cells from breast tumors has been reported. This study was undertaken to monitor expression of these...
20.
Krishan A, Ganjei-Azar P, Hamelik R, Sharma D, Reis I, Nadji M
Cytometry A . 2009 Nov; 77(2):132-43. PMID: 19899128
Diagnostic cytology based on the examination of cells from body cavity fluids misses approximately 50% of patients with a proven malignancy. In an earlier study, we used immunohistochemical detection of...